Vijaya Diagnostic Centre Limited (VIJAYA.BO)
INR 1059.65
(-1.01%)
INR 1059.65
(-1.01%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.82 Billion INR | -16.28% |
| 2022 | 4 Billion INR | 2.42% |
| 2021 | 3.9 Billion INR | 22.39% |
| 2020 | 3.19 Billion INR | 8.34% |
| 2019 | 2.94 Billion INR | 16.98% |
| 2018 | 2.51 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 934.67 Million INR | -2.2% |
| 2023 Q1 | 1.06 Billion INR | 1.23% |
| 2023 Q2 | 1.22 Billion INR | 14.75% |
| 2023 Q3 | 1.16 Billion INR | -4.74% |
| 2023 FY | 3.35 Billion INR | -16.28% |
| 2023 Q4 | 955.71 Million INR | -18.11% |
| 2022 Q1 | 913.29 Million INR | -6.87% |
| 2022 FY | 4 Billion INR | 2.42% |
| 2022 Q4 | 1.05 Billion INR | 6.04% |
| 2022 Q3 | 994.53 Million INR | -4.46% |
| 2022 Q2 | 1.04 Billion INR | 13.98% |
| 2021 Q2 | 964.68 Million INR | -5.05% |
| 2021 FY | 3.9 Billion INR | 22.39% |
| 2021 Q4 | 980.65 Million INR | 3.8% |
| 2021 Q3 | 944.76 Million INR | -2.06% |
| 2021 Q1 | 1.01 Billion INR | 6.44% |
| 2020 Q1 | 441.48 Million INR | 0.0% |
| 2020 Q2 | 938.46 Million INR | 112.57% |
| 2020 Q3 | 859.05 Million INR | -8.46% |
| 2020 FY | 3.19 Billion INR | 8.34% |
| 2020 Q4 | 954.51 Million INR | 11.11% |
| 2019 FY | 2.94 Billion INR | 16.98% |
| 2018 FY | 2.51 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 2.27 Billion INR | -112.391% |
| Dr. Lal PathLabs Limited | 14.62 Billion INR | 67.008% |
| Metropolis Healthcare Limited | 5.81 Billion INR | 17.021% |
| Thyrocare Technologies Limited | 2.5 Billion INR | -92.708% |
| Vimta Labs Limited | 1.08 Billion INR | -343.735% |